Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities
Archives of General PsychiatryPublished 1 October 2000
J. Street
Citations600
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Low-dose olanzapine (5 and 10 mg/d) was significantly superior to placebo and well tolerated in treating agitation/aggression and psychosis in this population of patients with AD.
Abstract
Low-dose olanzapine (5 and 10 mg/d) was significantly superior to placebo and well tolerated in treating agitation/aggression and psychosis in this population of patients with AD.
Keywords
PsychologyMedicine
Journal of Psychiatric Research“Mini-mental state”
86,858 Citations1975Marshal F. Folstein, Susan E. Folstein +1 more
A simplified, scored form of the cognitive mental status examination, the “Mini-Mental State” (MMS) which includes eleven questions, requires only 5-10 min to administer, and is therefore practical to use serially and routinely.
NeurologyClinical diagnosis of Alzheimer's disease
27,993 Citations1984Guy M. McKhann, David A. Drachman +4 more
The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information becomes available.
NeurologyThe Neuropsychiatric Inventory
7,559 Citations1994Jeffrey L. Cummings, Michael S. Mega +4 more
The NPI has the advantages of evaluating a wider range of psychopathology than existing instruments, soliciting information that may distinguish among different etiologies of dementia, differentiating between severity and frequency of behavioral changes, and minimizing administration time.
Acta Psychiatrica ScandinavicaA RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
3,263 Citations1970G. M. Simpson, M. B. +4 more
A modification of an earlier rating scale for extrapyramidal system disturbance is described, and evidence for the validity and reliability of the scale is presented.
The British Journal of PsychiatryA Rating Scale for Drug-Induced Akathisia
2,175 Citations1989Thomas R. E. Barnes
PsychopharmacologyRisperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
1,167 Citations1996Alain Schotte, Paul Janssen +6 more
In vitro, all compounds, except the ‘typical’ antipsychotics haloperidol and fluspirilene, showed higher affinity for 5HT2A than for D2 receptors, while in vivo, ORG-5222, risperidone, pipamperone, 9-OH-risperid one, sertindole, olanzapine, zotepine and clozapine maintained a higher potency for occupying 5HT
PubMedBehavioral symptoms in Alzheimer's disease: phenomenology and treatment.
1,114 Citations1987Barry Reisberg, Jeffrey Borenstein +4 more
Information regarding the characteristic phenomenology of the behavioral symptoms studied was used to design a clinical rating instrument for AD patients, the Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD), which should be useful in prospective studies of behavioral symptoms as well as in pharmacologic trials.
NeurologyThe spectrum of behavioral changes in Alzheimer's disease
1,109 Citations1996Michael S. Mega, Jeffrey L. Cummings +2 more
Agitation, dysphoria, apathy, and aberrant motor behavior were significantly correlated with cognitive impairment in patients with Alzheimer's disease compared with normal age-matched control subjects.
NeuropsychopharmacologyRadioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine
1,070 Citations1996Frank P. Bymaster, David O. Calligaro +6 more
The receptor binding profile of olanzapine is consistent with the antidopaminergic, antiserotonergic, and antimuscarinic activity observed in animal models and predicts atypical antipsychotic activity in man.
New England Journal of MedicineClozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United States
960 Citations1993Jose Ma. J. Alvir, Jeffrey A. Lieberman +3 more
The increasing risk of agranulocytosis with age and the reduced incidence after the first six months of treatment provide additional guidelines for the prescription and monitoring of clozapine treatment in the future.
The Journal of Clinical PsychiatryComparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia
746 Citations1999Ira R. Katz, Dilip V. Jeste +5 more
Results show that 1 mg/day of risperidone is an appropriate dose for most elderly patients with dementia, and significantly improved symptoms of psychosis and aggressive behavior in patients with severe dementia.
Journal of Clinical PsychopharmacologyDouble-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders
718 Citations1997Pierre V. Trân, S.H. Hamilton +5 more
Olanzapine seemed to have a risk-versus-benefit advantage in the management of psychotic symptoms, and the differential preclinical profiles of these two drugs were also evident in a controlled, clinical investigation.
NeuropsychopharmacologyDo Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence
714 Citations1998J. Arnt
The available evidence indicates that novel APDs and clozapine can be differentiated from haloperidol, particularly in models of EPS and cognitive side effects, however, among the group of novel APD there are many individual differences in models reflecting limbic versus striatal inhibition of dopamine function.
American Journal of PsychiatryOverview of depression and psychosis in Alzheimer's disease
684 Citations1989R E Wragg, Dilip V. Jeste
The authors reviewed 30 studies on Alzheimer's disease to determine the prevalence and phenomenology of affective and psychotic symptoms in patients with this disorder and found Paranoid delusions was the most common psychotic symptoms reported.
Journal of the American Geriatrics SocietyA Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
656 Citations1990Lon S. Schneider, Vicki E. Pollock +1 more
Clinically, neuroleptics treatment changed the improvement rate in agitated dementia patients from .41 to .59 (binomial effect‐size display), which indicates that 18 of 100 dementia patients benefited from neuroleptic treatment (beyond that of placebo) and is consistent with the modest efficacy described in previous qualitative reviews.
Journal of the American Geriatrics SocietyAssessing the Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: The Neuropsychiatric Inventory Caregiver Distress Scale
621 Citations1998Daniel Kaufer, Jeffrey L. Cummings +7 more
An adjunct scale to the Neuropsychiatric Inventory for assessing the impact of neuropsychiatric symptoms in Alzheimer's disease patients on caregiver distress is developed.
NeurologyA randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
618 Citations1999Peter Paul De Deyn, Kiran Rabheru +5 more
Low-dose risperidone (mean 1.1 mg/d) was well tolerated and associated with reductions in the severity and frequency of behavioral symptoms, particularly aggression, in elderly patients with dementia.
American Journal of PsychiatryOlanzapine Versus Placebo in the Treatment of Acute Mania
570 Citations1999Mauricio Tohen, T.M. Sanger +13 more
The olanzapine group experienced significantly greater mean mean scores than the placebo group in the treatment of acute mania, and the primary efficacy measure was defined as a change from baseline to endpoint in total score on the Young Mania Rating Scale.
American Journal of Geriatric PsychiatryThe Use of the Neuropsychiatric Inventory in Nursing Home Residents: Characterization and Measurement
483 Citations2000Stacey Wood, Jeffrey L. Cummings +5 more
The authors assessed the validity of the nursing home version of the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH), comparing the responses of certified nurses' aides and licensed vocational nurses with research observations.
American Journal of Geriatric PsychiatryPsychosis of Alzheimer's Disease and Related Dementias: Diagnostic Criteria for a Distinct Syndrome
391 Citations2000Dilip V. Jeste, Sanford I. Finkel
Clinical Pharmacology & TherapeuticsAntipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking
319 Citations1975Robert E. Vestal, Arthur H. Norris +4 more
The results suggest that studies attempting to quantify the effects of aging on drug metabolism must also take into account other factors that differ with age.
American Journal of PsychiatryLongitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease
256 Citations1996M L Levy, Jeffrey L. Cummings +4 more
Results indicate that once psychiatric symptoms are present in patients with Alzheimer's disease, they frequently recur, and these symptoms vary with age, sex, and rate of illness progression.
NeurologyNeuropsychiatric aspects of Alzheimer's disease
252 Citations1996Jeffrey L. Cummings, Daniel Kaufer
Investigation of the role of cholinergic dysfunction in the behavioral changes of AD will improve understanding of the pathophysiologic basis of these abnormalities and may lead to new types of therapy for the neuropsychiatric disturbances associated with this common dementing disorder.
American Journal of PsychiatryA Randomized, Placebo-Controlled Dose-Comparison Trial of Haloperidol for Psychosis and Disruptive Behaviors in Alzheimer’s Disease
238 Citations1998D. P. Devanand, Karen Marder +7 more
A favorable therapeutic profile for haloperidol in doses of 2-3 mg/day, although a subgroup developed moderate to severe extrapyramidal signs, may also apply to other neuroleptics used in Alzheimer's disease patients with psychosis and disruptive behaviors.
Drug Information JournalThe Application of the Principle of Intention–to–Treat to the Analysis of Clinical Trials
229 Citations1991Dennis B. Gillings, Gary G. Koch
A chronology of populations of patients eligible for analysis in clinical trials is discussed, and sensitivity analyses are proposed to address dilemmas as to which population of patients is appropriate for the final analysis of the trial.
Schizophrenia ResearchAntagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α1-adrenergic receptors in vitro
198 Citations1999Frank P. Bymaster
The Journal of Clinical PsychiatryQuetiapine, A Novel Antipsychotic
162 Citations1999Dennis Q. McManus, Lisa A. Arvanitis +2 more
Quetiapine was well tolerated in a nonrandomized study of elderly patients and was associated with improvement in symptoms, including significant improvement in Simpson-Angus Scale total score and CGI-Severity of Illness scores.
Journal of Pharmacokinetics and BiopharmaceuticsPharmacokinetics in the aged: A review
158 Citations1975E. J. Triggs, Roger L. Nation
The rate and extent of drug absorption do not appear to be altered to any appreciable degree in the elderly patient, but drug disposition in the aged subject may be affected by a number of factors including alterations in protein binding, apparent volumes of distribution, and renal and/or extrarenal clearance of the drug.
Journal of the American Geriatrics SocietyResident Behavior and Staff Distress in the Nursing Home
157 Citations1991Daniel E. Everitt, David R. Fields +2 more
Only half of the reported instances of behavior disorders were considered distressful by nursing home staff, and wandering was seen as distressful to staff only 50% of the time.
Mayo Clinic ProceedingsDrug Prescribing for Elderly Patients
107 Citations1995Darryl S. Chutka, Jonathan M. Evans +2 more
Medications for elderly patients should be prescribed only after the anatomic and physiologic changes of aging are understood and with increased surveillance for potential drug toxicity or adverse drug reactions.
NeurologyClinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease
105 Citations1997Soo Borson, Murray A. Raskind
It is argued that the origins of behavioral disturbances include both intrinsic neurobiological aspects of the disease and environmental provocations, and an approach to treatment decision-making that respects both the clinician's need to intervene to reduce suffering and the limitations of current knowledge is presented.
Archives of NeurologyA Pilot Study of Haloperidol Treatment of Psychosis and Behavioral Disturbance in Alzheimer's Disease
104 Citations1989D. P. Devanand, Harold A. Sackeïm +2 more
Nine outpatients meeting research criteria for probable Alzheimer's disease who had psychosis or behavioral disturbance participated in a single-blind, placebo-controlled pilot study, finding oral haloperidol in doses of 1 to 5 mg daily improved target symptoms and worsened Modified Mini-Mental State scores.
PubMedEfficacy of olanzapine: an overview of pivotal clinical trials.
102 Citations1997Charles M. Beasley, Gary D. Tollefson +1 more
Four double-blind pivotal studies suggest that olanzapine is as effective as haloperidol for positive symptoms and more effective than haloperodol for the treatment of the negative symptoms of schizophrenia.
Medical Entomology and ZoologyNursing home statistical yearbook
78 Citations1995Carey Cowles
An annual compendium of statistics on the nursing home industry, drawing on data from the Health Care Financing Administration (the governmental agency that administers Medicare and Medicaid).
American Journal of Geriatric PsychiatryClozapine in Older Patients With Psychosis and Behavioral Disruption
63 Citations1995Carl Salzman, Bernard Vaccaro +2 more
It is suggested that clozapine is possibly useful in controlling behavioral disruption in older patients with severe behavioral disruption secondary to psychotic symptoms, and older patients may be at greater risk for developing leukopenia because of their higher blood levels of clozAPine and possibly norclozapines.
Aging & Mental HealthAssessing the impact of neuropsychiatric symptoms on distress in professional caregivers
53 Citations1999Stacey Wood, Jeffrey L. Cummings +4 more
Agitation and apathy were found to be the two most distressing behaviors in the effects of neuropsychiatric symptoms among patients with dementia on distress in nursing home caregivers.
PubMedThe stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation.
51 Citations1989Barry Reisberg, Steven H. Ferris +5 more
The cross-sectional stage specific data on mental status and other measures can now be applied to the mean temporal course observations and the validity of the temporal estimates forwarded can be investigated in detail.
The British Journal of PsychiatryExtrapyramidal Signs, Primitive Reflexes and Frontal Lobe Function in Senile Dementia of the Alzheimer Type
50 Citations1990Deborah M. Girling, G. E. Berrios
Scores for cognitive function and for ‘frontal lobe’ signs were found to correlate well with scores for extrapyramidal signs, suggesting that they reflect changes in a common substratum.
PubMedClozapine use in female geriatric patients with psychoses.
50 Citations1995K. N. Roy Chengappa, Robert W. Baker +2 more
Both a low-dose and slow-titration strategy for initiating clozapine among elderly patients, similar to the use of other psychotropic drugs in the elderly, as well as close attention to postural hypotension, agranulocytosis, and drug interactions are suggested.
Journal of Geriatric Psychiatry and NeurologyClozapine in the Elderly
47 Citations1994Frances R. Frankenburg, Douglas Kalunian
The authors suggest that clozapine be considered in treating elderly psychotic patients, and that its use need not be restricted to schizophrenic patients.
European Journal of PharmacologyDecreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium
43 Citations2000Frank P Bymaster, Julie F. Falcone
The binding affinity of olanzapine, clozapine and atropine for muscarinic receptor subtypes in clonal Chinese hamster ovary (CHO) cell lines was compared in intact cells in physiological media to disrupted cells in hypotonic buffer to suggest that the affinity of OlanzAPine and clozAPine forMuscarinic receptors have been significantly overestimated.
Alzheimer Disease & Associated DisordersAssessment of Behavioral Symptoms in Alzheimer Disease
40 Citations1994Marian B. Patterson, John P. Bolger
Clinics in Geriatric MedicinePharmacodynamic Basis for Altered Drug Action in the Elderly
39 Citations1988Jay Roberts, Nihal Türner
The proper use of drugs in the elderly largely depends on taking into account both the pharmacokinetic and the pharmacodynamic properties of the drug and how these parameters are altered with age; such information can be obtained only by investigating drug action in older people.
Journal of Chronic DiseasesAging and drug disposition — Pharmacodynamics
39 Citations1983J. Crooks
The pharmacodynamics of a drug is defined as the effect of the drug on physiological functions and pathological processes and can be modified in the elderly by pharmacokinetics, receptor sensitivity, impaired homeostasis or pathology.
Journal of NeuropsychiatryDeterminants of SPontaneous Extrapyramidal Symptoms in Elderly Psychiatric Inpatients Diagnosed With Alzheimer's Disease, Major Depressive Disorder, or Psychotic Disorders
13 Citations1998Robert A. Sweet, Mayada Akil +4 more
It is suggested that rigidity is associated with DAT independently of any concurrent psychotic or depressive process, whereas bradykinesia does not appear to be specific to DAT among late-life neuropsychiatric illnesses.
Schizophrenia ResearchOlanzapine in the treatment of elderly patients with schizophrenia and related psychotic disorders
8 Citations1998Stephen G Reams, T.M. Sanger +1 more